• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核苷酸多态性 rs1319501 和内脂素/NAMPT 影响子痫前期一氧化氮的形成、sFlt-1 和降压治疗反应。

single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia.

机构信息

Graduate Program in Genetics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Department of Biophysics & Pharmacology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil.

出版信息

Pharmacogenomics. 2021 Jun;22(8):451-464. doi: 10.2217/pgs-2021-0006. Epub 2021 May 4.

DOI:10.2217/pgs-2021-0006
PMID:33944612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9552901/
Abstract

We examined the relationships between visfatin/NAMPT and nitrite concentrations (a marker of nitric oxide [NO] formation) or sFlt-1 levels in 205 patients with preeclampsia (PE) responsive or nonresponsive to antihypertensive therapy, and whether SNPs rs1319501 and rs3801266 affect nitrite concentrations in PE and 206 healthy pregnant women. Circulating visfatin/NAMPT and sFlt-1 levels were measured by ELISA, and nitrite concentrations by using an ozone-based chemiluminescence assay. In nonresponsive PE patients, visfatin/NAMPT levels were inversely related to nitrite concentrations and positively related to sFlt-1 levels. SNP rs1319501 affected nitrite concentrations in nonresponsive PE patients and was tightly linked with functional SNPs in Europeans. SNP rs1319501 and visfatin/NAMPT affect NO formation, sFlt-1 levels and antihypertensive therapy response in PE.

摘要

我们研究了 205 例先兆子痫(PE)患者对降压治疗有反应和无反应者中内脂素/NAMPT 与亚硝酸盐浓度(一氧化氮 [NO] 形成的标志物)或可溶性血管内皮生长因子受体 1(sFlt-1)水平之间的关系,以及 SNP rs1319501 和 rs3801266 是否影响 PE 中及 206 例健康孕妇的亚硝酸盐浓度。采用 ELISA 法测定循环内脂素/NAMPT 和 sFlt-1 水平,采用基于臭氧的化学发光法测定亚硝酸盐浓度。在无反应性 PE 患者中,内脂素/NAMPT 水平与亚硝酸盐浓度呈负相关,与 sFlt-1 水平呈正相关。SNP rs1319501 影响无反应性 PE 患者的亚硝酸盐浓度,与欧洲人群中的功能 SNP 紧密相关。SNP rs1319501 和内脂素/NAMPT 影响 PE 患者的 NO 形成、sFlt-1 水平和降压治疗反应。

相似文献

1
single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia.单核苷酸多态性 rs1319501 和内脂素/NAMPT 影响子痫前期一氧化氮的形成、sFlt-1 和降压治疗反应。
Pharmacogenomics. 2021 Jun;22(8):451-464. doi: 10.2217/pgs-2021-0006. Epub 2021 May 4.
2
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.烟酰胺磷酸核糖转移酶(NAMPT)途径中的基因-基因相互作用、血浆内脂素/NAMPT水平与妊娠期高血压疾病的降压治疗反应性
Pharmacogenomics J. 2017 Oct;17(5):427-434. doi: 10.1038/tpj.2016.35. Epub 2016 May 10.
3
Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.NAMPT 多态性和单倍型对妊娠高血压疾病患者循环中内脂素/NAMPT 水平的影响。
Hypertens Res. 2015 May;38(5):361-6. doi: 10.1038/hr.2015.15. Epub 2015 Feb 26.
4
NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia.子痫前期患者中,NAMPT 水平与一氧化氮生成呈负相关,与可溶性 fms 样酪氨酸激酶-1 水平呈正相关。
Pregnancy Hypertens. 2019 Oct;18:137-140. doi: 10.1016/j.preghy.2019.09.022. Epub 2019 Oct 11.
5
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.烟酰胺磷酸核糖转移酶单倍型和代谢危险因素对儿童肥胖症患者循环内脂素/烟酰胺磷酸核糖转移酶水平的影响。
Int J Obes (Lond). 2015 Jan;39(1):130-5. doi: 10.1038/ijo.2013.173. Epub 2013 Sep 12.
6
single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia.单核苷酸多态性 rs3742879 影响先兆子痫患者的血浆精氨酸酶 2 水平、一氧化氮形成和降压治疗反应。
Pharmacogenomics. 2022 Aug;23(13):713-722. doi: 10.2217/pgs-2022-0079. Epub 2022 Aug 16.
7
The interplay between extracellular NAMPT and inflammatory cytokines in preeclampsia.子痫前期中外细胞 NAMPT 与炎症细胞因子的相互作用。
J Reprod Immunol. 2024 Jun;163:104248. doi: 10.1016/j.jri.2024.104248. Epub 2024 Apr 10.
8
Longitudinal Study of Plasma Visfatin/Nicotinamide Phosphoribosyltransferase (NAMPT) Levels in Healthy Pregnant Women.健康孕妇血浆内视黄醇结合蛋白 4(Visfatin/Nicotinamide Phosphoribosyltransferase,NAMPT)水平的纵向研究。
Reprod Sci. 2023 Oct;30(10):2893-2895. doi: 10.1007/s43032-023-01246-4. Epub 2023 Apr 28.
9
Potential roles of visfatin/NAMPT on endothelial dysfunction in preeclampsia and pathways underlying cardiac and vascular remodeling.内脂素/烟酰胺磷酸核糖转移酶在子痫前期内皮功能障碍中的潜在作用以及心脏和血管重塑的潜在机制。
J Cell Physiol. 2022 Jan;237(1):10-12. doi: 10.1002/jcp.30572. Epub 2021 Sep 6.
10
A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver disease.黏附素基因启动子多态性(rs1319501)与非酒精性脂肪性肝病易感性相关。
Per Med. 2023 Mar;20(2):157-165. doi: 10.2217/pme-2022-0100. Epub 2023 May 18.

引用本文的文献

1
Correlation Analysis of NAMPT rs61330082 Polymorphism in Type 2 Diabetes Mellitus Combined with Hypertension.2型糖尿病合并高血压患者中NAMPT基因rs61330082多态性的相关性分析
Diabetes Metab Syndr Obes. 2024 Apr 18;17:1809-1818. doi: 10.2147/DMSO.S458416. eCollection 2024.
2
Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications.子痫前期的降压治疗反应性与不良结局:对心血管和肾脏并发症潜在分子机制的见解
Front Pharmacol. 2023 Nov 22;14:1281382. doi: 10.3389/fphar.2023.1281382. eCollection 2023.
3
The Potential Role of Visfatin in Mediating Vascular Dysfunction and Hypertension.内脂素在介导血管功能障碍和高血压中的潜在作用
J Cardiovasc Pharmacol. 2023 Nov 1;82(5):347-349. doi: 10.1097/FJC.0000000000001457.
4
Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia.胎盘缺血对先兆子痫中正常 NOS 介导的血管张力和血压控制说“不”。
Int J Mol Sci. 2021 Oct 19;22(20):11261. doi: 10.3390/ijms222011261.

本文引用的文献

1
Noncoding SNPs associated with increased GDF15 levels located in a metformin-activated enhancer region upstream of .与 GDF15 水平升高相关的非编码 SNPs 位于. 的上游被二甲双胍激活的增强子区域内。
Pharmacogenomics. 2020 Jun;21(8):509-520. doi: 10.2217/pgs-2020-0010. Epub 2020 May 19.
2
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.内脏脂肪素/烟酰胺磷酸核糖转移酶在体内诱导血管内皮功能障碍:Toll 样受体 4 和 NLRP3 炎性体的作用。
Sci Rep. 2020 Mar 25;10(1):5386. doi: 10.1038/s41598-020-62190-w.
3
NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia.子痫前期患者中,NAMPT 水平与一氧化氮生成呈负相关,与可溶性 fms 样酪氨酸激酶-1 水平呈正相关。
Pregnancy Hypertens. 2019 Oct;18:137-140. doi: 10.1016/j.preghy.2019.09.022. Epub 2019 Oct 11.
4
Pre-eclampsia: pathogenesis, novel diagnostics and therapies.子痫前期:发病机制、新的诊断方法和治疗方法。
Nat Rev Nephrol. 2019 May;15(5):275-289. doi: 10.1038/s41581-019-0119-6.
5
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension.血管心脏肿瘤学:血管内皮生长因子抑制剂与高血压。
Cardiovasc Res. 2019 Apr 15;115(5):904-914. doi: 10.1093/cvr/cvz022.
6
Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions.内皮型一氧化氮合酶基因多态性与基因相互作用的药物遗传学相关性。
Pharmacogenomics. 2018 Dec;19(18):1423-1435. doi: 10.2217/pgs-2018-0098. Epub 2018 Nov 6.
7
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.妊娠期轻度至中度高血压的抗高血压药物治疗。
Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD002252. doi: 10.1002/14651858.CD002252.pub4.
8
Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions.高血压与子痫前期的药物基因组学:聚焦基因-基因相互作用
Front Pharmacol. 2018 Feb 28;9:168. doi: 10.3389/fphar.2018.00168. eCollection 2018.
9
GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.基因增强子:基因卡片中增强子与靶基因的全基因组整合
Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax028.
10
Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.子痫前期治疗中的药物遗传学:当前研究结果、挑战与展望
Pharmacogenomics. 2017 Apr;18(6):571-583. doi: 10.2217/pgs-2016-0198. Epub 2017 Mar 30.